FDA Eases Way for Gold-Standard Biosimilars
May 10, 2019
Jeff Overley
Law360
Axinn partner Stacie Ropka was quoted in the Law360 article, "FDA Eases Way for Gold-Standard Biosimilars."
Click here to access the article. A subscription is required.
Axinn partner Stacie Ropka was quoted in the Law360 article, "FDA Eases Way for Gold-Standard Biosimilars."
Click here to access the article. A subscription is required.